Mr Mrs Miss Ms Dr Other

Dr
Charles
Harding

Partner & Chair of HGF's Pharma & Life Sciences Contentious Practice

London Office

Life sciences

Telephone. +44 (0)207 776 5100
Email. charding@hgf.com
UPC Representative
Our team of specialist European patent litigators, oppositions specialists and patent attorneys bring together an extensive depth of legal and technical knowledge and are qualified to represent you in the UPC.

Experience

As a result of many years of experience in the patent profession, including time spent in both private practice and in-house, Charles has a deep experience across the life sciences arena.

Charles has over 35 years’ advocacy experience before the Opposition Divisions and Appeal Boards of the EPO covering a wide spectrum of biological and chemical technologies - with many cases enabling the continued development of actual and potential pharmaceuticals and medicaments. He has also had representation before the EPO Enlarged Board of Appeal.

Charles is considered to have a foundational reputation and is a recognised as a thought leader. He was inducted in the Legal 500 Hall of Fame in 2025.

From 2021 to 2024, he was Honorary Professor, Centre for Commercial Studies of Queen Mary University London.

Charles has a passion for innovation in the life sciences arena. For his contribution to science, Charles was elected a Fellow of the Royal Society of Chemistry in 2024.

Qualifications

Patent Attorney

Chartered (UK)
Europe


BSC

BSc Hons Biochemistry

BSC

BSc Hons Chemistry

PHD

Medicinal Chemistry - Design and synthesis of novel clinical diagnostic contrast agents

OTHER

Fellow of the Royal Society of Chemistry

Related News

Event - 27th October 2026

HGF sponsors pro-manchester Retail Lunch 2026

HGF is delighted to be sponsoring pro-manchester Retail Lunch 2026, taking place on Tuesday 27 October 2026 at INNSiDE by Meliá in Manchester. As part of the event, HGF Partner …

Event details
HGF

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article
HGF

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article
Event - 12th November 2026

HGF Partners with PPTI for 'Designing Foods for Healthy Aging' Webinar

As healthy aging, metabolic health and weight management rise up the consumer agenda, food and nutrition businesses are increasingly looking beyond traditional product development and towards solutions that deliver measurable …

Event details

Basel Seminar: Seminar on the new EU Pharma Package and its implications for regulatory exclusivities in the EU

Venue – Der Teufelhof Basel, Switzerland We are pleased to invite you to our seminar on the new EU Pharma Package and its implications for regulatory exclusivities in the EU. …

Read article
Event - 28th October 2026

HGF Attending BMCS Antibody–Drug Conjugates 2026

HGF is pleased to announce that Dr Thomas Lonsdale, Patent Director, will be attending the BMCS Antibody–Drug Conjugates 2026 meeting, taking place on 19 November 2026 at GSK, Stevenage, UK. …

Event details

Hsu Min Chung Recognised in IAM Global Leaders 2027

HGF is delighted to announce that Partner, Hsu Min Chung, has been recognised in the IAM Global Leaders 2027 guide, a prestigious ranking that highlights some of the world’s leading …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.